Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

Tesla CEO Elon Musk calls for making weight loss drugs super low cost to improve American health, aligning with healthcare ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to ...

Elon Musk, one of President-elect Donald Trump’s closest confidants, revealed Wednesday his support for weight-loss drugs ...

Soon it will be the new year, which means new year’s resolutions — and a very common one is weight loss. People on social ...

The childhood obesity epidemic in GCC countries has triggered a debate on the potential use of weight-loss medications such ...

A mum-of-two died after taking weight loss drugs to shed excess weight after a battle with cancer. Sarah Thompson, 34, was ...

Wegovy and other GLP-1 medications have become extremely popular over the past few years. Novo Nordisk (which makes both ...

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). I was asked to discuss the topic on ...

Mondelez International’s latest overture to Hershey underscores the challenges posed by high cocoa prices and penny-pinching consumers, which could make the company more open to a deal.

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...